Global Molecular Cytogenetics Market (2013 – 2019)

REPORT DESCRIPTION
Molecular Cytogenetics Market is Expected to Reach USD 1.97 Billion Globally in
2019: Transparency Market Research
Transparency Market Research published new market report "Molecular Cytogenetics
Market (Technologies: FISH and aCGH; Applications: Genetic Disorders, Cancer
and Personalized Medicine) - Global Industry Analysis, Size, Share, Growth, Trends
and Forecast, 2013 - 2019," the global molecular cytogenetics market was valued at USD
469.2 million in 2012 and is estimated to reach a market worth USD 1.97 billion in 2019 at
a CAGR of 23.4% from 2013 to 2019.
Molecular cytogenetics is emerging as an indispensable tool in the field of research and
diagnosis. Until the advent of molecular cytogenetics techniques in 1980s, chromosomal
analysis was mainly based on banding patterns. Although, the traditional banding
techniques encountered problems such as low resolution and poor quality analysis.
Transparency Market Research
Molecular Cytogenetics
Market (Technologies:
FISH and aCGH;
Applications: Genetic
Disorders And Cancer) -
Global Industry Analysis,
Size, Share, Growth,
Trends and Forecast, 2013
– 2019
Multi User License: US $ 7595
Corporate User License: US $ 10595
Buy Now
Request Sample
Published Date: Aug 2013
96 Pages Report

Browse the full report at
http://www.transparencymarketresearch.com/molecular-diagnostics-
market.html
However, breakthrough in fluorescence in situ hybridization (FISH) and array-comparative
genomic hybridization (aCGH) techniques has enhanced the diagnosis of chromosomal
anomalies particularly in tumor and hematological malignancies. Nowadays, cytogenetics
techniques are being considered mandatory in diagnosis and prognosis of leukemia. The
techniques are considered as a standard laboratory test since they provide global screening
of abnormalities. The scope of molecular cytogenetics is increasing with the rising cancer
incidences worldwide and growing popularity of personalized medicines.
The ability of FISH technique to study cells at an interphase stage of the cell cycle has made
the technique a breakthrough in molecular cytogenetics field. FISH technique is used in the
research of diverse applications such as cancer, cardiovascular and genetic disorder. The
impetus of FISH technique is a direct result of improved understanding of sequence,
structure and function of human genome. Similarly, supported by technological
advancements in fluorescent microscopes and digital imaging, FISH technique has emerged
as a preferred tool in molecular cytogenetics. The technique facilitates the analysis of sub-
chromosomal regions and the identifications of small translocations thereby, routinely used
in clinical applications. Owing to the techniques' sensitivity and specificity, FISH is
significantly used in number of cytogenetic and pathological laboratories.
The advent of aCGH is ushering new standards for the analysis of genome. The technology
has turned out to be a greatest driver for the molecular cytogenetics market as it is
overcoming the resolution problems associated with traditional banding techniques. aCGH is
poised to witness a significant growth in the market and is likely to emerge as the fastest
growing technology segment. aCGH has propelled the cytogenetics market from the
microscopes to computers and thus, facilitated simultaneous analysis of thousands of
discrete regions of the genome. Similarly, the technique is gaining popularity as one assay
performed on this technique is comparable to thousands of FISH experiments and hence,
saves time and cost. Moreover, the technique is expected to rapidly supplant FISH
technique owing to further technological advancements in the technique. Likewise,
increasing sensitivity of the aCGH technique is preferred as a primary diagnosis tool
followed by validation with FISH. The technique is emerging as a powerful tool for high
resolution analysis of sub-microscopic chromosomal abnormalities. aCGH is also evolving as
a method of choice for molecular cytogenetics by the researchers owing to its work flow
advantages and cost effectiveness.
North America accounts for the largest share of the molecular cytogenetics market followed
by the European region. The markets for these regions are driven by factors such as
increased level of public awareness, rising cancer incidences and large number of research
institutes engaged in cytogenetics field. However, Asia-Pacific region is likely to emerge as
the fastest growing region over the analysis period. Cancer diagnosis is likely to witness a

significant growth and emerge as the fastest growing segment during analysis period with a
CAGR of more than 20%.
The growing demand for molecular cytogenetics techniques in research and data
interpretation has resulted in quick expansion of manufacturers' product portfolio. The
manufacturers are focused on building aggressive strategies for the development of
innovative products that would cater research and diagnostic sectors. The vendors are eager
to tap the emerging regions and end-users of this market. Major players engaged in
development of innovative molecular cytogenetics techniques are Abbott laboratories,
Affymetrix, Inc., Applies Spectral Imaging, BI Biological Industries, Life Technologies
Corporation, Roche Diagnostics, Oxford Gene Technology, Illumina, Inc., among others.
The molecular cytogenetics market is segmented as follows:
Molecular Cytogenetics Market, by Technology
 FISH
 aCGH
Molecular Cytogenetics Market, by Application
 Genetic Disorders
 Cancer
 Personalized Medicine
 Others
Molecular Cytogenetics Market, by Geography
 North America
 Europe
 Asia-Pacific
 RoW
TABLE OF CONTENTS
Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology

market.html
Chapter 2 Executive Summary
2.1 Market Snapshot: Global Molecular Cytogenetics Market (2012 & 2019)
2.2 Global Molecular Cytogenetics Market, by Technology, 2012 (USD Million)
2.3 Global Molecular Cytogenetics Market, by Application, 2012 (USD Million)
Chapter 3 Market Overview
3.1 Introduction
3.2 Market Drivers
3.2.1 Introduction of advanced technologies
3.2.2 Rising incidence of cancer cases
3.3 Market Restraints
3.3.1 Issues with medical reimbursement
3.4 Market Opportunities
3.4.1 Advent of Next Generation Sequencing
3.4.2 Tapping the emerging economies
3.5 Porter’s Five Forces Analysis
3.5.1 Bargaining power of buyers
3.5.2 Bargaining power of suppliers
3.5.3 Threat of new entrants
3.5.4 Threat of substitutes
3.5.5 Competitive rivalry
3.6 Market Attractiveness Analysis
3.7 Market Share Analysis, by Key Players (%)

3.7.1 Global Molecular Cytogenetics Market Share Analysis, by Key Players (%)
3.8 End User Analysis
3.8.1 Global Molecular Cytogenetics End User Analysis
Chapter 4 Molecular Cytogenetics Market, by Technology
4.1 Overview
4.1.1 Global Molecular Cytogenetics Market, by Technology, 2011 – 2019 (USD Million)
4.2 Fluorescence in situ hybridization (FISH)
4.2.1 Global FISH Market, 2011 – 2019 (USD Million)
4.3 Array-Comparative Genomic Hybridization (aCGH)
4.3.1 Global aCGH Market, 2011 – 2019 (USD Million)
Chapter 5 Molecular Cytogenetics Market, by Applications
5.1 Overview
5.1.1 Global Molecular Cytogenetics Market, by Application, 2011 – 2019 (USD Million)
5.2 Cancer
5.2.1.1 Global Cancer Application Market, 2011 – 2019 (USD Million)
5.3 Personalized Medicines
5.3.1.1 Global Personalized Medicine Application Market, 2011 – 2019 (USD Million)
5.4 Genetic Disorders
5.4.1.1 Global Genetic Disorder Application Market, 2011 – 2019 (USD Million)
5.5 Others (Neurological, Cardiovascular and Infectious Diseases)
5.5.1.1 Global Others Application Market, 2011 – 2019 (USD Million)

Chapter 6 Molecular Cytogenetics Market, by Geography
6.1 Overview
6.1.1 Global Molecular Cytogenetics Market, by Geography, 2011 – 2019 (USD Million)
6.2 Comparative Analysis: Molecular Cytogenetics Market, by Geography, 2012 & 2019
(Value %)
6.3 North America
6.3.1 North America Molecular Cytogenetics Market, by Technology, 2011 – 2019 (USD
Million)
6.3.2 North America Molecular Cytogenetics Market, by Applications, 2011 – 2019 (USD
Million)
6.4 Europe
6.4.1 Europe Molecular Cytogenetics Market, by Technology, 2011 – 2019 (USD Million)
6.4.2 Europe Molecular Cytogenetics Market, by Applications, 2011 – 2019 (USD Million)
6.5 Asia-Pacific
6.5.1 Asia-Pacific Molecular Cytogenetics Market, by Technology, 2011 – 2019 (USD
Million)
6.5.2 Asia-Pacific Molecular Cytogenetics Market, by Applications, 2011 – 2019 (USD
Million)
6.6 RoW
6.6.1 RoW Molecular Cytogenetics Market, by Technology, 2011 – 2019 (USD Million)
6.6.2 RoW Molecular Cytogenetics Market, by Applications, 2011 – 2019 (USD Million)
Chapter 7 Recommendations
7.1 Investment in emerging economies
7.2 Mergers and Acquisitions

market.html
Chapter 8 Company Profiles
8.1 Abbott Laboratories
8.1.1 Company Overview
8.1.2 Financial Overview
8.1.3 Product Portfolio
8.1.4 Business Strategies
8.1.5 Recent Developments
8.2 Affymetrix, Inc.
8.2.4 Business Strategy
8.3 Agilent Technologies, Inc.
8.4 Applied Spectral Imaging, Inc.

8.5 BI Biological Industries
8.6 Bio-Rad Laboratories
8.6.1 Company overview
8.7 CytoTest Inc.
8.8 Cytognomix, Inc.
8.9 F. Hoffmann-La Roche Ltd.

8.10 Illumina Inc.
8.11 LEICA BIOSYSTEMS
8.11.5 Recent Development
8.12 Life Technologies Corporation
8.13 Oxford Gene Technology

8.14 PerkinElmer, Inc.
8.15 SciGene Corporation
About Us:
Transparency Market Research is a market intelligence company providing global business
information reports and services. Our exclusive blend of quantitative forecasting and trends
analysis provides forward-looking insight for thousands of decision makers.
We are privileged with highly experienced team of Analysts, Researchers and Consultants,
who use proprietary data sources and various tools and techniques to gather, and analyze
information. Our business offerings represent the latest and the most reliable information
indispensable for businesses to sustain a competitive edge.
Contact:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Global Molecular Cytogenetics Market (2013 – 2019)

Recommandé

Recommandé

Contenu connexe

Dernier

Dernier (20)

En vedette

En vedette (20)

Global Molecular Cytogenetics Market (2013 – 2019)